How important it is to prioritize a portfolio of projects with the best chance of market success

Feb. 6, 2012 - PRLog -- Join SMi at their 7th annual Pharmaceutical Portfolio & Lifecycle Management that will address the challenges associated with obtaining an optimal portfolio of projects. Senior level industry executives will discuss key strategies and management approaches essential to effective portfolio and lifecycle management.

Reasons to attend include:

•   Gain knowledge of how to successfully combine and implement multiple projects

•   Examine ideas for Lifecycle management of the portfolio

•   Measure portfolio value and risk

•   Evaluate LCM - making the most of every brand!

•   Assess early stage strategies and intellectual property

•   Determine lifecycle management effectiveness

•   Discover the importance of maximizing introduction, growth and maturity phases to increase revenue

•   Network with top pharma companies and universities

Top speaker line up includes:

Tony Ellery, Managing Director, Ellery Pharma Consulting, Former Global Head LCM in Portfolio Management, Novartis
Kimber Hardy, Head of Valuation and Analysis, Merck Serono
Tim Harris, Director, Respiratory & Immuno-inflammation Portfolio Management, GlaxoSmithKline
Shafique Virani, Global Head CNS Business Development, F. Hoffman La Roche
Sakir Mutevelic, Head of Global Project Management Biopharmaceuticals Hemophilia A/WD, Baxter
Christiano Pereira Silva, Global Product Manager for Pradaxa, Boehringer-Ingelheim
Julie Barrett-Major, Director of Intellectual Property, Norgine
Alan S. Harris, Senior Vice President, Global Projects & Portfolio Management, Ferring Pharmaceuticals
Christine Deuschel, Vice President Portfolio & Project Management, Debiopharm
Anne Lane, Executive Director, University College London Business

For further details and to register visit http://www.smi-online.co.uk/pharma-portfolio37.asp alternatively contact Fateja Begum on tel +44 0207 827 6184